United States News All stories

Bitcoiners turned bullish after Elon Musk forecast double-digit US economic growth, even as some analysts warned of a potential Bitcoin bear market in 2026.

Social engineering scams cost the crypto industry billions in 2025, with experts warning that human manipulation, not code flaws, is now the biggest security risk.

Bitcoin bears hold the advantage heading into a $30.3 billion year-end options expiry as prices remain below the key $94,000 resistance level.

Crypto dealmaking hit a record $8.6 billion in 2025 as Trump-era deregulation boosted mergers, acquisitions and IPO activity across the digital asset sector.

Kraken’s anticipated IPO and rising M&A activity could help draw fresh traditional finance capital and extend what some fund managers see as crypto’s mid-stage market cycle.

HashKey Capital has raised $250 million at the first close of its fourth crypto fund, underscoring continued institutional confidence in digital assets despite volatile market conditions.

The US ETF market hit a historic triple crown in 2025, while crypto fund flows rotated away from Bitcoin and Ethereum toward XRP and Solana.

Kraken says blockchain tokenisation is expanding the definition of money beyond fiat, allowing users to trade and store value in almost any asset.

Dragonfly VC says Solana and Ethereum can both thrive in the tokenisation race, arguing the market has room for multiple blockchains.

Nvidia’s $20 billion Groq deal underscores its strategy of absorbing AI chip rivals, intensifying debate over decentralised alternatives to its growing dominance.

Canton’s CC token surged over 25% on Christmas Eve as institutional progress on regulated tokenisation fuelled demand despite weak market sentiment.

Jim Cramer has turned fully bearish on Bitcoin, a shift traders are watching closely as ETF outflows and extreme fear grip the market.

Nearly three in ten Americans, and almost half of Gen Z, want crypto for Christmas despite tighter budgets caused by persistent living cost pressures.

Polymarket says recent account hacks were caused by a vulnerability in a third-party login service rather than flaws in its core protocol.

Former Alameda Research CEO Caroline Ellison is set for early release from US custody in January following her conviction in the FTX collapse.

The Philippines has ordered ISPs to block Coinbase and Gemini, escalating a crackdown on unlicensed crypto exchanges operating in the country.

The NFA has accused Japan-based Forex Wizard of misleading investors, running an undisclosed forex pool and delaying a $500,000 withdrawal.

The CFTC has formally closed its six-year civil spoofing case against former JPMorgan metals traders, imposing fines and long-term market bans.

Binance has listed Kyrgyzstan’s som-pegged KGST stablecoin as the country accelerates legislation, reserves and national plans around digital assets.

Omeros Corporation (NASDAQ:OMER) said the U.S. Food and Drug Administration approved YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, marking the first authorized therapy for the life-threatening condition.

Repare Therapeutics (NASDAQ:RPTX) has entered into a definitive asset purchase agreement to sell its polymerase theta (Polθ) ATPase inhibitor, RP-3467, to Gilead Sciences (NASDAQ:GILD) for up to $30 million.

Edgewise Therapeutics (NASDAQ:EWTX) said it has completed Parts B and C of the CIRRUS-HCM study and reported favorable interim safety data from Part D for EDG-7500, its selective oral cardiac sarcomere modulator being developed for obstructive and nonobstructive hypertrophic cardiomyopathy

Stonepeak, the New York-based alternative investment firm, has reached an agreement to acquire a 65% controlling interest in Castrol from BP (NYSE:BP), the companies announced Wednesday.

Agios Pharmaceuticals (NASDAQ:AGIO) announced today that the U.S. Food and Drug Administration (FDA) has approved AQVESME™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia.